Masato Ozaka

ORCID: 0000-0002-5666-1970 · 1 paper in corpus · active 2025
2025
Impact of Second-line Combination Chemotherapy on Post-progression Survival in Metastatic and Recurrent Pancreatic Cancer
·doi:10.21203/rs.3.rs-5965079/v1

Abstract Background: This study aimed to evaluate the efficacy of the second-line combination chemotherapy (CC) for patients with metastatic or recurrent pancreatic cancer. Methods: We retrospectively analyzed consecutive patients with met…